Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rifampicin-resistant tuberculosis in Spain.

ERJ open research·2026
Same author

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

BMJ open respiratory research·2025
Same author

Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2021
Same author

Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2019
Same author

Correction to: Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis.

Infection·2019
Same author

Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis.

Infection·2019

Related Experiment Video

Updated: Jun 3, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis in special populations.

Miguel Santín Cerezales1, Enrique Navas Elorza

  • 1Servicio de Enfermedades Infecciosas, Hospital Universitario de Bellvitge, IDIBELL, Departamento de Ciencias Clínicas, Universidad de Barcelona, Red Española de Investigación en Patología Infecciosa, Instituto de Salud Carlos III, Barcelona, Spain. msantin@bellvitgehospital.cat

Enfermedades Infecciosas Y Microbiologia Clinica
|March 23, 2011
PubMed
Summary

Tuberculosis (TB) risk and presentation vary with host immunity, influenced by age, comorbidities, and other factors. This impacts diagnosis and treatment, especially in Spain

Related Experiment Videos

Last Updated: Jun 3, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Host immunological status significantly influences tuberculosis (TB) susceptibility, pathogenesis, and clinical presentation.
  • Factors like age, comorbidities, immunosuppressive therapies, and immigration impact TB epidemiology.
  • Aging populations and immigration from high-incidence countries present unique challenges for TB control in Spain.

Purpose of the Study:

  • To summarize current knowledge on epidemiological, clinical, and treatment aspects of TB.
  • To highlight challenges in diagnosing and managing TB in susceptible populations.
  • To address the impact of host immunity and demographic shifts on TB control.

Main Methods:

  • Review of epidemiological data on TB incidence and reactivation.
  • Analysis of clinical manifestations, including extrapulmonary TB.
  • Examination of treatment challenges related to drug toxicity and interactions.
  • Consideration of immigration as a factor in TB epidemiology.

Main Results:

  • TB presentation is often atypical in susceptible populations, leading to delayed diagnosis.
  • Extrapulmonary TB and drug-related toxicities complicate management.
  • Aging demographics and immigration increase the burden of TB in Spain.
  • Host immunity is a critical determinant of TB outcomes.

Conclusions:

  • TB management in susceptible populations requires tailored approaches due to complex clinical and immunological factors.
  • Addressing atypical presentations and treatment complexities is crucial for effective TB control.
  • Public health strategies must consider demographic changes and immigration patterns to combat TB effectively.